Listing of New BMRB NMR-STAR files

Entries released in the last month, starting from most recent release to least recent one.
The latest entries may not be immediately available here or through the BMRB database search. They can be found in "entry lists" under "FTP access".

Entry IDRelease DateTitle
53109 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53113 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53112 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53108 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53106 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53105 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53103 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53102 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53101 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53099 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53097 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53098 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53119 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53118 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53117 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53116 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53115 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
53114 2026-01-06Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule
52443 2026-01-05Convergent evolution of intrinsically disordered regions in vertebrate galectins for liquid-liquid phase separation
52970 2026-01-05Bora Bridges Aurora-A Activation and Substrate Recognition of PLK1
53417 2026-01-05Solution NMR Assignment of the MCM6 NTD1 Domain Reveals No Detectable Binding to BLM MBD-N and MBD-D Regions
53493 2025-12-301H and 15N chemical shift assignments of K11-linked di-ubiquitin
31261 2025-12-30Structure of the disulfide-rich modules of a striking tandem repeat protein, avian cysteine-rich eggshell membrane protein
31270 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31271 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31272 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31273 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31274 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31275 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31276 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31277 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
31278 2025-12-30Backbone engineering in the hydrophobic core of villin headpiece
53492 2025-12-30Backbone 1H and 15N chemical shift assignments of His-tagged M1-linked di-ubiquitin
31178 2025-12-30NMR structure of the Tetrahymena Slr1 La Motif
52757 2025-12-29Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
52760 2025-12-29Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
52759 2025-12-29Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
52758 2025-12-29Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
53084 2025-12-26Acidic bicelles are a suitable membrane mimic for structural studies of the Lassa virus fusion domain
53439 2025-12-26STI1 domain dynamically engages transient helices in disordered regions to drive self-association and phase separation of yeast ubiquilin Dsk2
53085 2025-12-26Acidic bicelles are a suitable membrane mimic for structural studies of the Lassa virus fusion domain
53342 2025-12-201H, 13C and 15N backbone resonance assignment of the lytic polysaccharide monooxygenase LsAA9A from Lentinus similis
52291 2025-12-20WDR5 Reshapes Nanog Prion-like Structure to Sustain Pluripotency in Embryonic Stem Cells
52290 2025-12-20WDR5 Reshapes Nanog Prion-like Structure to Sustain Pluripotency in Embryonic Stem Cells
53402 2025-12-20Conformational Preferences for N-glycans at the Surface of CEACAM1-Ig1
53244 2025-12-20Loop of Fate: Structural and Mechanistic Insights into hnRNPA1 Binding to the Hepatitis C Virus RNA
53451 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53445 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53446 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53447 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53448 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53449 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53450 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53452 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53453 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53454 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53252 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53253 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53254 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53255 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53256 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53257 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53258 2025-12-16Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
53425 2025-12-16Histidine-rich coiled-coils promote zinc-dependent self-assembly and curing of porous mussel glues
53441 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53442 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53443 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
53444 2025-12-16HEXIM1 inter-monomer autoinhibition governs 7SK RNA binding specificity and P-TEFb inactivation
34968 2025-12-15R2TP-like complexes as quaternary chaperones. A comprehensive overview to understand the dynamic R2SP complex
34969 2025-12-15NMR solution structure of RPRD2 CTD-interacting domain and pS2,7 RNAPII CTD peptide.
36434 2025-12-15Interaction between a fluoroquinolone derivative and RNAs with a single bulge.
36600 2025-12-15Solution NMR Structure of Vaccinia Virus Protein J5 (2 - 68 a.a)
34920 2025-12-15Three-dimensional structure of the Merozoite surface protein 1 C-terminal domain from P. berghei
36696 2025-12-15Development of Nanomolar Affinity Miniprotein Inhibitors Targeting alpha-Synuclein Aggregation as Promising Therapeutic Agents for Parkinson’s Disease
36621 2025-12-15Different DNA Binding and Damage Mode between Anticancer Antibiotics Trioxacarcin A and LL-D49194a1.
36641 2025-12-15Different DNA Binding and Damage Mode between Anticancer Antibiotics Trioxacarcin A and LL-D49194a1.
36627 2025-12-15Different DNA Binding and Damage Mode between Anticancer Antibiotics Trioxacarcin A and LL-D49194a1.